Prelude Capital Management, LLC Cytokinetics Inc Call Options Transaction History

Prelude Capital Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$47.86 - $75.05 $4,786 - $7,505	100 Added 2.5%	4,100 $222,000
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $255,000 - $432,240	4,000 New	4,000 $280,000
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $13,734 - $25,749	-900 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$20.58 - $28.96 $18,522 - $26,064	900 New	900 $19,000

406

125M

4.6M

2.42M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.35B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.